Last Updated: 02/12/2024
Pre-clinical development of a pan-species, multi-stage universal vaccine for the malaria eradication agenda
Objectives
To develop a broad-spectrum ‘universal’ vaccine effective against infective sporozoites, disease-causing blood-stages and transmissible sexual stages of most species of human malaria.
Principal Institution
Principal Investigators / Focal Persons
External reference
Themes
Date
Nov 2015 — Dec 2018
Total Project Funding
$1.76M
Funding Details
Gates Foundation (GF), United States
Global Grant challenges: New interventions for global health
Grant ID: OPP1136441
Country / Project Site(s)
Related Resources
